Abstract Background Eugenol (1-allyl-4-hydroxy-3-methoxybenzene) is an important simple
phenolic compound mainly derived from Syzygium aromaticum and many other plants. It is …

Since the beginning of history, natural products have been an abundant source of bioactive
molecules for the treatment of different diseases, including cancer. Many allyl derivatives …

Scope Eugenol (EU), the major aromatic compound derived from clove oil, is being focused
recently due to its potential in preventing several chronic conditions. Herein, this study aims …

Semisynthetic modifications of natural products have bestowed us with many anticancer
drugs. In the present work, a natural product, eugenol, has been modified synthetically to …

Background: Cancer is, at present, among the leading causes of morbidity globally. Despite
advances in treatment regimens for cancer, patients suffer from poor prognoses. In this …

The clove (Syzygium aromaticum) is an important tropical spice crop in global trade.
Evolving environmental pressures necessitate modern characterization and selection …

Molecular docking in the pharmaceutical industry is a powerful in silico approach for
discovering novel therapies for unmet medical needs predicting drug–target interactions. It …

Syzygium aromaticum is an aromatic plant native to Indonesia, and introduced to tropical
regions worldwide. As an ingredient in perfumes, lotions, and food preservation, it is widely …

Simple Summary The migratory and invasive pathways that evolve in the early stage of
colorectal cancer (CRC) are crucial in developing the metastatic cascade and drug …

Natural products and their semi-synthetic analogues have provided many chemotherapeutic
drugs. In the current study, eugenol, a natural anticancer agent, has been modified …